Key result
In stable CHD patients, depressive mood (OR 6.08; 95% CI 2.92-12.7) and anxiety (OR 8.66; 95% CI 3.77-19.89) were associated with impaired quality of life, but not with global cardiovascular risk.
Why the study?
Depression and anxiety have been suggested to increase cardiovascular risk, but their prevalence and relations to conventional risk profiles, mortality, morbidity, and quality of life in stable CHD patients remained to be assessed.
Do depression and anxiety increase mortality, morbidity, or impair quality of life in stable coronary heart disease patients?
Cohort (n=969)
Do depression and anxiety increase mortality, morbidity, or impair quality of life in stable coronary heart disease patients?
Odds Ratio: 6.08 (95% CI 2.92–12.7)
In stable coronary heart disease patients, mood disorders significantly impair quality of life but do not independently increase the risk of mortality or major cardiovascular events.
Mood disorders may warrant screening to address QoL in stable CHD; leaves open any link to cardiovascular risk.
Background: It was suggested that depression and anxiety might be associated with increased cardiovascular risk in both primary and secondary prevention. In stable coronary heart disease (CHD) patients, we aimed to assess prevalence of depression and anxiety, its relations to conventional risk profile and mortality or morbidity and to quality of life (QoL).Methods: We examined 969 patients, at least 6 months after myocardial infarction or coronary revascularisation. Depression or anxiety was assessed using a standard HADS (Hospital Anxiety and Depression Scale), while QoL by SF-36 (Short-Form-36 Questions) questionnaires. Follow-up was done to assess mortality in incidence of non-fatal cardiovascular event.Results: Both mood disorders were rather frequent; borderline depression or anxiety (HADS score 8–10) had 14.8 or 10.9% of patients, respectively; moderate-to-severe depression or anxiety (HADS score ≥11) had another 8.2 or 6.7% of patients. After adjustment for potential covariates impaired QoL (SF-36 score <40) was independently associated with depressive mood [odds ratio (OR) 6.08 (95%CI: 2.92–12.7) or anxiety [OR 8.66 (95%CI: 3.77–19.89)], as well as with combination of both disorders [OR 33.58 (95%CI: 15.5–72.6)]. Conventional risk characteristics remained virtually unrelated to mood disorders (with exception of angina pectoris). We found significantly higher incidence of major cardiovascular events in patients with anxious mood and marginally significant inferior survival in patients with depression, but any cardiovascular risk disappeared if adjusted for potential covariates (conventional risk factors, natriuretic peptides, angina pectoris.)Conclusions: Mood disorders severely affected QoL of stable CHD patients, but not their global cardiovascular risk.
No takes yet. Share an insight, caveat, or question.
Mayer et al. (2019) conducted a cohort in Stable coronary heart disease (n=969). Depressive mood or anxiety vs. Absence of mood disorders was evaluated on Impaired quality of life (SF-36 score <40) (OR 6.08, 95% CI 2.92-12.7). In stable CHD patients, depressive mood (OR 6.08; 95% CI 2.92-12.7) and anxiety (OR 8.66; 95% CI 3.77-19.89) were associated with impaired quality of life, but not with global cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: